PL2037950T3 - Dodatkowe zastosowania medyczne białka antysekrecyjnego - Google Patents

Dodatkowe zastosowania medyczne białka antysekrecyjnego

Info

Publication number
PL2037950T3
PL2037950T3 PL07748080T PL07748080T PL2037950T3 PL 2037950 T3 PL2037950 T3 PL 2037950T3 PL 07748080 T PL07748080 T PL 07748080T PL 07748080 T PL07748080 T PL 07748080T PL 2037950 T3 PL2037950 T3 PL 2037950T3
Authority
PL
Poland
Prior art keywords
medical uses
further medical
antisecretory protein
antisecretory
protein
Prior art date
Application number
PL07748080T
Other languages
English (en)
Inventor
Hans-Arne Hansson
Original Assignee
Lantmaennen As Faktor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantmaennen As Faktor Ab filed Critical Lantmaennen As Faktor Ab
Publication of PL2037950T3 publication Critical patent/PL2037950T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL07748080T 2006-04-27 2007-04-27 Dodatkowe zastosowania medyczne białka antysekrecyjnego PL2037950T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE0600933 2006-04-27
US92082607P 2007-03-30 2007-03-30
PCT/SE2007/000415 WO2007126365A2 (en) 2006-04-27 2007-04-27 Further medical uses of antisecretory protein
EP07748080.4A EP2037950B1 (en) 2006-04-27 2007-04-27 Further medical uses of antisecretory protein

Publications (1)

Publication Number Publication Date
PL2037950T3 true PL2037950T3 (pl) 2014-09-30

Family

ID=38655930

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07748080T PL2037950T3 (pl) 2006-04-27 2007-04-27 Dodatkowe zastosowania medyczne białka antysekrecyjnego

Country Status (10)

Country Link
US (1) US8487074B2 (pl)
EP (1) EP2037950B1 (pl)
JP (2) JP5508846B2 (pl)
KR (1) KR20090037992A (pl)
AU (1) AU2007244005B2 (pl)
CA (1) CA2650132C (pl)
IL (1) IL194775A (pl)
MX (1) MX2008013777A (pl)
PL (1) PL2037950T3 (pl)
WO (1) WO2007126365A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008013769A (es) * 2006-04-27 2009-02-03 Lantmaennen As Faktor Ab Uso de factores antisecretores para el tratamiento de hipertension intraocular.
AU2007244005B2 (en) 2006-04-27 2012-08-02 Lantmannen As-Faktor Ab Further medical uses of antisecretory protein
CN101437533B (zh) 2006-04-27 2016-10-12 兰特门内阿斯-法克托尔公司 抗分泌蛋白对于治疗间室综合症的应用
US9220750B2 (en) 2007-04-27 2015-12-29 Lantmannen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
US9962424B2 (en) 2007-04-27 2018-05-08 Lantmännen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
US8901083B2 (en) 2008-11-25 2014-12-02 Temple University Administration of angiocidin for the treatment of leukemia
WO2017009004A1 (en) 2015-07-10 2017-01-19 Lantmännen As-Faktor Ab Process for producing egg yolk with high content of af-16
US11407796B2 (en) 2016-07-18 2022-08-09 Lantmännen As-Faktor Ab Antisecretory factor 17
CA3103164A1 (en) * 2018-06-28 2020-01-02 Lantmannen Medical Ab Antisecretory factor for use in treatment and/or prevention of acute respiratory failure
US20240085429A1 (en) * 2021-01-22 2024-03-14 University Of Virginia Patent Foundation Altering protein function by pharmacological targeting of membrane domains

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585401A (en) 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
SE508609C2 (sv) 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
EP0876483A1 (en) * 1996-01-26 1998-11-11 HSC Research and Development Limited Partnership Nucleic acids and proteins related to alzheimer's disease, and uses therefor
SE506486C2 (sv) 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
GB0322645D0 (en) * 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
AU2007244005B2 (en) 2006-04-27 2012-08-02 Lantmannen As-Faktor Ab Further medical uses of antisecretory protein
CN101437533B (zh) * 2006-04-27 2016-10-12 兰特门内阿斯-法克托尔公司 抗分泌蛋白对于治疗间室综合症的应用
EP2682819A2 (en) * 2012-07-04 2014-01-08 Xeikon IP B.V. A method for forming a multi-colour image

Also Published As

Publication number Publication date
IL194775A (en) 2015-09-24
US20090149382A1 (en) 2009-06-11
JP2009535330A (ja) 2009-10-01
WO2007126365A8 (en) 2009-03-05
AU2007244005B2 (en) 2012-08-02
JP6063401B2 (ja) 2017-01-18
WO2007126365A3 (en) 2008-03-13
US8487074B2 (en) 2013-07-16
AU2007244005A1 (en) 2007-11-08
MX2008013777A (es) 2009-02-03
JP2014111623A (ja) 2014-06-19
IL194775A0 (en) 2011-08-01
KR20090037992A (ko) 2009-04-17
WO2007126365A2 (en) 2007-11-08
CA2650132A1 (en) 2007-11-08
EP2037950A2 (en) 2009-03-25
JP5508846B2 (ja) 2014-06-04
CA2650132C (en) 2017-10-24
EP2037950B1 (en) 2014-04-23
HK1128237A1 (en) 2009-10-23

Similar Documents

Publication Publication Date Title
AU312971S (en) Patient interface
PL2164349T3 (pl) Bezproteinowa mieszanka dla niemowląt
GB0718972D0 (en) Compounds and methods of making the compounds
IL193604A (en) Use of human anti-22 @ il antibodies for @ preparation
IL197221A0 (en) Protein purification
IL199547A (en) Preparation of romidapsine
GB0705854D0 (en) Methods of construction
GB0618930D0 (en) Medical implant
AU313136S (en) Patient interface
GB2440734B (en) Coffin
IL208396A0 (en) Guided surgery
ZA200902300B (en) Use of modified cyclosporins
GB0910201D0 (en) The preparation method of 2-deoxy-l-ribose
EP1912499A4 (en) PREPARATION OF MONTELUKAST
PT1857252T (pt) Dispositivo médico
GB0601976D0 (en) Proteins
GB2442217B (en) Gaiter
GB2437917B (en) Walking aid
GB0623740D0 (en) Treatment of disease
GB0612443D0 (en) Protein
GB0620304D0 (en) Protein
PL381142A1 (pl) Sposób otrzymywania glicydolu
GB0612370D0 (en) Uses of (S)-clenbuterol
HU0600620D0 (en) New medical use of localanesthetics
GB0601552D0 (en) New medical uses